Sage Journals: Discover world-class research

Retricted access

Review article

First published 2016-10

Idarucizumab for Reversal of Dabigatran-Associated Anticoagulation

Dinesh Yogaratnam, Kristen Ditch, Kristin Medeiros [...]

Annals of Pharmacotherapy

Retricted access

Review article

First published 2015-12

Idarucizumab,a Humanized,Monoclonal Antibody Fragment for Immediate Reversal of Dabigatran

Marta A. Miyares, Yara Kuyumjian, Shannon Eaves [...]

Journal of Pharmacy Practice

Open access

Research article

First published 2025

Dabigatran-idarucizumab pharmacokinetics-pharmacodynamics in sheep undergoing cardiopulmonary bypass

Michael P Eaton, Sergiy M Nadtochiy, Tatsiana Stefanos [...]

Perfusion

Open access

Research article

First published 2017-6

Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany – A national case collection

Pawel Kermer, Christoph C Eschenfelder, Hans-Christoph Diener [...]

International Journal of Stroke

Retricted access

Research article

First published 2020-8

Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany—Updated series of 120 cases

Pawel Kermer, Christoph C Eschenfelder, Hans-Christoph Diener [...]

International Journal of Stroke

Retricted access

Case report

First published 2019-12

Case Report of Endovascular Thrombectomy in Severe Acute Ischemic Stroke After Dabigatran Reversal with Idarucizumab

Sandeep Nayani, Rajesh Reddy Chenna, Rajesh Reddy Sannareddy [...]

Journal of Stroke Medicine

Retricted access

Case report

First published 2022-4

Refractory Dabigatran-Induced Hemorrhage Despite Multiple Idarucizumab Administration and Renal Replacement Therapy

Francis Flynn, Guillaume Richard, Marc A. Dobrescu [...]

Journal of Pharmacy Practice

Open access

Research article

First published 2022

Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds

Alex C. Spyropoulos, Bríain Ó Hartaigh, Zhun Cao [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Case report

First published 2018

Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab

Gian Galeazzo Riario Sforza, Francesco Gentile, Fabio Stock [...]

Sage Open Medical Case Reports

Open access

Research article

First published 2018-7

The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination

Stephan Glund, Guanfa Gan, Viktoria Moschetti [...]

Clinical and Applied Thrombosis/Hemostasis

Search results